Key result
Platelet-specific targets and novel anti-inflammatory agents acting against them represent a potential therapeutic approach for managing thrombo-inflammatory diseases.
Design
Review
Authors
Loading...
Hypothesis-generating for platelet targets in thrombo-inflammation; leaves open clinical translation pending rigorous trials.
Targeting platelet-specific inflammatory pathways represents a potential therapeutic approach for thrombo-inflammatory diseases.
Wichaiyo et al. (2021) conducted a review in Inflammatory diseases. Anti-platelet and anti-inflammatory drugs targeting platelet-specific molecules was evaluated. Platelet-specific targets and novel anti-inflammatory agents acting against them represent a potential therapeutic approach for managing thrombo-inflammatory diseases.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: